Long-term outcome of the Milano-hyperfractionated accelerated radiotherapy strategy for high-risk medulloblastoma, including the impact of molecular subtype
2024 · Neuro-Oncology · 6 citations
https://doi.org/10.1093/neuonc/noae189
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
19
Citations
3
h-index
0
i10-index
Chiara Dossena is an academic researcher from Fondazione IRCCS Istituto Nazionale dei Tumori. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Gut microbiota and health & Cancer Genomics and Diagnostics. The author has an h-index of 3, co-authored 6 publications.
ORCID: 0009-0003-0260-8052https://doi.org/10.1093/neuonc/noae189
https://doi.org/10.1038/s41392-025-02290-z
Click to start Chat